Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%

CVE-2021-39078

EPSS 0.02% · P7
Get alerts for future matching vulnerabilitiesLog in to subscribe

I. Basic Information for CVE-2021-39078

Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM Security Guardium 10.5 stores user credentials in plain clear text which can be read by a local privileged user. IBM X-Force ID: 215589.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM Security Guardium 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM Security Guardium是美国IBM公司的一套提供数据保护功能的平台。该平台包括自定义UI、报告管理和流线化的审计流程构建等功能。 IBM Security Guardium 10.5 版本存在安全漏洞,该漏洞源于 IBM Security Guardium 以纯明文形式存储用户凭证。本地特权用户可以读取该凭证。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

VendorProductAffected VersionsCPESubscribe
IBMSecurity Guardium 10.5 -

II. Public POCs for CVE-2021-39078

#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2021-39078

登录查看更多情报信息。

Same Patch Batch · IBM · 2022-04-19 · 4 CVEs total

CVE-2021-39076IBM Security Guardium 加密问题漏洞
CVE-2021-39072IBM Security Guardium 安全漏洞
CVE-2021-39033IBM Sterling B2B Integrator 安全漏洞

IV. Related Vulnerabilities

V. Comments for CVE-2021-39078

No comments yet


Leave a comment